Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 16, 408-412, June 1, 1956]
© 1956 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herbut, P. A.
Right arrow Articles by Kraemer, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herbut, P. A.
Right arrow Articles by Kraemer, W. H.

Heterologous Transplantation of Human Tumors

Peter A. Herbut and William H. Kraemer

( Elizabeth Storck Kraemer Memorial Foundation and Department of Pathology, Jefferson Medical College and Hospital, Philadelphia, Pa.)

Two hundred and six malignant human tumors were transplanted subcutaneously in irradiated (150 r) weanling Wistar rats treated with cortisone (3-mg. doses). Growth occurred in only one instance—that of an anaplastic carcinoma from the ascending colon of a 77-year-old woman. At the present time the tumor has been cultivated for 10 months and is being maintained in sixteen animals in the 24th generation. It has also been successfully transplanted serially into animals receiving irradiation alone (150 r or 300 r) and cortisone (6-mg. doses) alone. It has not, however, been successfully transplanted into untreated, normal animals.

In considering the protective mechanism of animals against heterologously transplanted tissue, it is suggested that properdin may play the leading role and that this euglobulin may be the natural tumor inhibitor in the animal body.

Received 11/21/55.


This article has been cited by other articles:


Home page
Arch Intern MedHome page
R. J. WEDGWOOD
Immunity, Infection, and Properdin
Arch Intern Med, September 1, 1959; 104(3): 497 - 505.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1956 by the American Association for Cancer Research.